- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
July 30th, 2007
The story of a nanotechnology start-up
PharmaTelevision talks to Professor Tom Rademacher a professor at University College London (UCL)'s Immunology & Molecular Pathology Department, and President of Midatech, about the formation of the Midatech, Professor Rademacher's fifth start-up company. Midatech is focused on exploring the possibilities of nanotechnology, particularly for medical therapeutic and diagnostic applications.
Specifically, the company is a manufacturer of biocompatible nanoparticles called nanocells. They possess a number of unique properties that make them ideal for therapeutics, diagnostics and other enabling applications.
|Related News Press|
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Researchers create a first frequency comb of time-bin entangled qubits: Discovery is a significant step toward multi-channel quantum communication and higher capacity quantum computers April 28th, 2016
Superfast light source made from artificial atom April 28th, 2016
Are humans the new supercomputer?Today, people of all backgrounds can contribute to solving serious scientific problems by playing computer games. A Danish research group has extended the limits of quantum physics calculations and simultaneously blurred the boundaries between mac April 14th, 2016
UCLA nanoscientists engage shoppers in fun conversations March 8th, 2016
Risk Analysis Publishes Non-Animal Strategy to Assess Nanomaterials February 24th, 2016